NCT02154763View on ClinicalTrials.gov

The Use of Intraperitoneal Ropivacaine in Bariatric Bypass Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

July 31, 2015

Conditions
Bariatric Surgery Candidate
Interventions
DRUG

Ropivacaine

DRUG

Normal Saline

Trial Locations (1)

K1Y 4E9

The Ottawa Hospital, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER